FAP and neoplasm: Although alpha emitters have a higher LET (greater by a factor 500) and shorter ranges (50–100 μm), which may reduce toxicity burden and improve tumor cell killing, the role of 225Ac in FAP-targeted RPT remains unknown [4, 13].